Phibro Animal Health (PAHC): Raising PT - Guggenheim

September 12, 2016 6:28 AM EDT
Get Alerts PAHC Hot Sheet
Price: $25.73 --0%

Rating Summary:
    5 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 9 | New: 8
Trade PAHC Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Guggenheim analyst, Brandon Folkes, reiterated his Buy rating on shares of Phibro Animal Health Corp. (NASDAQ: PAHC) and raised his price target to $30 from $26 on multiple expansion.

The analyst stated "we expect the headwinds from medically important antibiotics to subside in F2H17 post the deadline for compliance with the antibiotic regulations, and we believe the negative sentiment driven by consumer preference that caused a move away from antibiotic use in the U.S. has overshadowed an important growth driver in the PAHC business model: growth in the demand for PAHC’s products driven by the need for more efficient protein production in developing markets".

No definitive catalysts were highlighted in the note.

For an analyst ratings summary and ratings history on Phibro Animal Health Corp. click here. For more ratings news on Phibro Animal Health Corp. click here.

Shares of Phibro Animal Health Corp. closed at $25.83 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change

Related Entities


Add Your Comment